Research Analysts Issue Forecasts for HURN FY2024 Earnings

Huron Consulting Group Inc. (NASDAQ:HURN) – Analysts at William Blair boosted their FY2024 EPS estimates for Huron Consulting Group in a research note issued to investors on Wednesday, October 30th. William Blair analyst A. Nicholas now anticipates that the business services provider will earn $6.09 per share for the year, up from their previous forecast of $6.06. The consensus estimate for Huron Consulting Group’s current full-year earnings is $5.95 per share. William Blair also issued estimates for Huron Consulting Group’s Q1 2025 earnings at $1.14 EPS, Q3 2025 earnings at $2.04 EPS and FY2025 earnings at $7.00 EPS.

Huron Consulting Group (NASDAQ:HURN) last announced its quarterly earnings results on Tuesday, October 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.11. The firm had revenue of $370.00 million during the quarter, compared to the consensus estimate of $377.63 million. Huron Consulting Group had a return on equity of 20.44% and a net margin of 5.46%. The firm’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.39 EPS.

A number of other research analysts have also recently commented on the stock. Barrington Research reissued an “outperform” rating and set a $137.00 target price on shares of Huron Consulting Group in a research report on Monday, September 9th. StockNews.com upgraded shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Benchmark reissued a “buy” rating and issued a $140.00 price objective on shares of Huron Consulting Group in a research report on Wednesday. Five analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $131.75.

Huron Consulting Group Price Performance

HURN stock opened at $115.73 on Thursday. The stock has a 50-day simple moving average of $107.27 and a 200-day simple moving average of $100.56. The firm has a market cap of $2.06 billion, a P/E ratio of 25.16 and a beta of 0.61. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.93 and a current ratio of 1.93. Huron Consulting Group has a 1 year low of $84.26 and a 1 year high of $118.10.

Insider Transactions at Huron Consulting Group

In other Huron Consulting Group news, Director Hugh E. Sawyer III sold 3,000 shares of the firm’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $104.09, for a total transaction of $312,270.00. Following the completion of the transaction, the director now directly owns 23,802 shares of the company’s stock, valued at $2,477,550.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO C. Mark Hussey sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $103.13, for a total transaction of $412,520.00. Following the sale, the chief executive officer now directly owns 81,081 shares of the company’s stock, valued at approximately $8,361,883.53. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Hugh E. Sawyer III sold 3,000 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $104.09, for a total value of $312,270.00. Following the transaction, the director now owns 23,802 shares in the company, valued at $2,477,550.18. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 10,348 shares of company stock valued at $1,081,897. 2.02% of the stock is currently owned by corporate insiders.

Institutional Trading of Huron Consulting Group

Several institutional investors have recently added to or reduced their stakes in HURN. Covestor Ltd boosted its holdings in shares of Huron Consulting Group by 26,500.0% in the 1st quarter. Covestor Ltd now owns 266 shares of the business services provider’s stock valued at $26,000 after buying an additional 265 shares during the period. Ashton Thomas Private Wealth LLC bought a new position in shares of Huron Consulting Group during the second quarter valued at approximately $28,000. Daiwa Securities Group Inc. raised its position in shares of Huron Consulting Group by 800.0% during the 1st quarter. Daiwa Securities Group Inc. now owns 1,800 shares of the business services provider’s stock worth $174,000 after purchasing an additional 1,600 shares during the period. Dakota Wealth Management bought a new stake in shares of Huron Consulting Group in the 2nd quarter worth approximately $219,000. Finally, Creative Planning boosted its position in Huron Consulting Group by 10.5% during the 3rd quarter. Creative Planning now owns 2,588 shares of the business services provider’s stock valued at $281,000 after purchasing an additional 246 shares during the period. Institutional investors own 93.90% of the company’s stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.